Faculty Profile

Dag Morten Dalen

Professor - Research and Academic Resources


Dag Morten Dalen is the provost and senior vice president of BI Norwegian Business School, with the overall responsibility for the quality of degree programmes at bachelor, master, phd and executive level. Dalen holds a professor position in economics, and has published widely in the area of industrial organization and industry regulation. 

In his more recent research Dalen has been studying competition, prescription choices and regulation in pharmaceutical markets Dalen has extensive consulting experience from projects with ministries, regulatory authorities and private companies, covering topics related to competition policy, regulation of network industries, health economics and quality assurance of larger public investment projects.

In 1997-1998 Dalen worked full-time for the Parliamentary Commission for the investigation of the Norwegian Banking Crisis, and in 2004-2005 he was a member of the Norwegian Ministry of Administration and Labour Expert Commission on Competition between Public and Private Enterprises. 


Research interests
Industrial economics, Economics of regulation, Pharmaceutical markets


Dalen, Dag Morten; Locatelli, Marilena, Sorisio, Enrico & Strøm, Steinar (2014)

Does the Identity of the Third-Party Payer Matter for Prescribing Doctors?

Applied Economics and Finance, 1(1) Doi: 10.11114/aef.v1i1.324

Brekke, Kurt; Dalen, Dag Morten & Holmås, Tor Helge (2014)

Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs

European Journal of Health Economics, 15(9), s. 937- 951. Doi: 10.1007/s10198-013-0536-6 - Fulltekst i vitenarkiv

This article studies the diffusion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries covering the period from the first launch in 2000 until becoming blockbusters in 2009. Descriptive statistics reveal large variations across countries in per-capita consumption and price levels both overall and at the brand level. We explore potential sources for the cross-country consumption differences by estimating several multivariate regression models. Our results show that large parts of the cross-country variation are explained by time-invariant country-specific factors (e.g., disease prevalence, demographics, health care system). We also find that differences in income [gross domestic product (GDP) per capita] and health spending (share of GDP) explain the cross-country variation in consumption, while relative price differences seem to have limited impact.

Dalen, Dag Morten & Moen, Espen R (2012)

Ownership and Cost-Sharing Contracts

Australian Economic Papers, 51(3), s. 134- 146. Doi: 10.1111/j.1467-8454.2012.00428.x

Brekke, Kurt; Dalen, Dag Morten & Strøm, Steinar (2012)

Should pharmaceutical costs be curbed?

Nordic Economic Policy Review, 2, s. 1- 27.

Pharmaceuticals account for almost a fifth of total health spending in OECD-countries. Both pharmaceutical innovations and the aging of the population explain the increasing importance of pharmaceuticals in health care. Due to the importance of patent protection and insurance coverage, pharmaceutical markets are subjected to economic regulation – both on the supply-side and the demand-side. In this paper, we briefly review the Nordic pharmaceutical market, before explaining the main regulatory policy measures taken by governments in these countries. Empirical re-search has been undertaken to investigate regulation and competition, and we provide a review of some of the findings.

Dalen, Dag Morten; Hoel, Michael Olaf & Strøm, Steinar (2011)

Markedsmakt og innovasjon på norsk sokkel

Samfunnsøkonomen, 65(3), s. 40- 45.

Dalen, Dag Morten; Furu, Kari, Locatelli, Marilena & Strøm, Steinar (2011)

Generic substitution: micro evidence from register data in Norway

European Journal of Health Economics, 12(1), s. 49- 59. Doi: 10.1007/s10198-010-0226-6

Dalen, Dag Morten; Hoel, Michael & Strøm, Steinar (2008)

Kalkulasjonsrenten på lang sikt i en usikker verden


Dalen, Dag Morten & Strøm, Steinar (2006)

The pharmaceutical market in Norway

Competition and Welfare: The Norwegian Experience, ed. Lars Sørgard

Dalen, Dag Morten; Strøm, Steinar & Haabeth, Tonje (2006)

Price regulation and generic competition in the pharmaceutical market

European Journal of Health Economics, 7, s. 208- 214.

Dalen, Dag Morten; Moen, Espen R. & Riis, Christian (2006)

Contract renewal and incentives in public procurement

International Journal of Industrial Organization, 24(2), s. 269- 285.

This paper explores how the government's choice of renewal policy in public procurement programs can be used as a mechanism to provide firms with incentives to supply quality. A public service is produced by several firms. The firms participate in a tournament where they are ranked according to the quality of their services, and rewarded in terms of contract renewals. We analyse the firms' incentives to produce high-quality services, and find that they are maximised if 50% of the contracts are renewed. The optimal renewal policy trades off incentive provision (which requires that a relatively large fraction of the firms are replaced each period) against the entry costs of new firms. (c) 2005 Elsevier B.V. All rights reserved.

Dalen, Dag Morten & Gomez-Lobo, Andres (2003)

Yardsticks on the road: Regulatory contracts and cost efficiency in the Norwegian Bus Industry

Transportation, 30, s. 371- 368.

Dalen, Dag Morten; Fehr, Nils-H. M. Von der & Moen, Espen R. (2003)

Regulation with Wage Bargaining

Economic Journal, 113(487), s. 525- 538.

Dalen, Dag Morten (2001)

Reformer i helsesektoren - politikk og økonomisk realiteter


Dalen, Dag Morten & Lund, Arild J. (2001)

Håndtering av finansielle kriser: Norges banks rolle

Økonomisk forum, 55(3), s. 12- 17.

Dalen, Dag Morten; Moen, Espen R. & Riis, Christian (2001)

Public Ownership as a Signalling Device

Nordic Journal of Political Economy, 27(1), s. 3- 12.

Dalen, Dag Morten (2000)

Regulering og internasjonal regelverkskonkurranse

NOU 2000:9 Konkurranseflater i finansnæringen

Dalen, Dag Morten (2000)

Konkurranseutsetting av offentlige tjenester

Sosialøkonomen, 54(7), s. 23- 28.

Dalen, Dag Morten (2000)

Catching-up investemnet without regulatory commitment

Journal of Regulatory Economics, 18, s. 133- 150.

Dalen, Dag Morten (1998)

Yardstick competition and investment incentives


Dalen, Dag Morten (2009)

Private enforcement of predatory pricing law

[Academic lecture]. The Fourth International Conference on Competition and Regulation (CRESSE.

Dalen, Dag Morten (2009)

Reimbursement policy and physicians’ choice of biopharmaceuticals: The case of TNF-alpha inhibitors

[Academic lecture]. Helseøkonomikonferansen.

Dalen, Dag Morten (2009)

Sykehusenes legemiddelanbud. Konkurranse på hvilke vilkår?

[Article in business/trade/industry journal]. Samfunnsøkonomen

Dalen, Dag Morten & Grammeltvedt, Thor-Erik (2008)

The efficient public owner of a public utility: Too many to be true?

[Academic lecture]. EEA ESEM 2008.

Bjørnenak, Trond; Dalen, Dag Morten, Dalen, Dag Morten, Fehr, Nils-H. M. Von der, Olsen, Trond E. & Torsvik, Gaute (2005)

På like vilkår? Analyse av konkurranse mellom offentlige og private foretak

[Scientific book]. Konkurransetilsynet.

Academic Degrees
Year Academic Department Degree
1996 University of Oslo Ph.D Dr. Polit.
1991 University of Oslo Master Cand. Oecon
Work Experience
Year Employer Job Title
2010 - Present BI Norwegian Business School Provost - Senior Vice President
2006 - Present BI Norwegian Business School Associate Dean, MSc in Business and Economics
2004 - Present BI Norwegian Business School Professor
2006 - 2007 BI Norwegian Business School Acting Head of Department
1998 - 2004 BI Norwegian Business School Associate Professor
1999 - 2000 Central Bank of Norway Senior advisor (part time)
1997 - 1998 Stortinget (The Norwegian Parliament) Advisor
1996 - 1998 SNF-Oslo Researcher
1992 - 1996 University of Oslo, Dept. of Economics Research fellow